Tiago Girao

Chief Financial Officer

Tiago Girao (Chief Financial Officer) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Immunovant, Inc. (IMVT). The largest single filing was $763K of IMVT (25,760 sh × $29.62, as filed), executed Apr 23.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 3 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$1.4M

shares × price, as filed

Last traded

Jul 23

Filed Jul 24

Median ADV $75.6M across their filed names

Open performance→

Volume by month

Buys $0 Sells $1.4M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 3 filings

Sector per market data · by filing · past 12 months

Most traded names

IMVT

Immunovant, Inc. IMVT · 0 buys · 3 sells 3 filings

Recent filings

IMVTSALE Immunovant, Inc. View filing → $263K
6,798 sh × $38.69
Exec Jul 23
Filed Jul 24 · 5:57 PM ET IMVTSALE Immunovant, Inc. View filing → $385K
10,000 sh × $38.46
Exec Jun 26
Filed Jun 26 · 5:30 PM ET IMVTSALE Immunovant, Inc. View filing → $763K
25,760 sh × $29.62
Exec Apr 23
Filed Apr 24 · 5:30 PM ET